Medicines Optimization Prior to Discharge in Patients Admitted to Hospital with Heart Failure
Joseph J. Cuthbert(University of Hull), Andrew L. Clark(University of Bedfordshire), John G.F. Cleland(University of Glasgow), Jeanne Bulemfu(Castle Hill Hospital), Karen Dobbs(Castle Hill Hospital), Pierpaolo Pellicori(University of Glasgow), Ioanna Sokoreli(Philips (Netherlands)), Oliver Brown(University of Leeds), Syed Jamil Hasan Kazmi(University of Hull), Steffan C. Pauws(NXP (Netherlands)), Jarno Riistama(Philips (Netherlands))
Cited by 4
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Journal of Heart Failure|2022|2.1k
Rosuvastatin in Older Patients with Systolic Heart Failure
|New England Journal of Medicine|2007|1.5k
State of the Art: Using Natriuretic Peptide Levels in Clinical Practice
|European Journal of Heart Failure|2008|837